Klingman & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $680K | Buy |
|
|||||
|
2025
Q2 | $501K | Buy |
|
|||||
|
2025
Q1 | $514K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $233K | Sell |
|
|||||
|
2023
Q4 | $348K | Sell |
|
|||||
|
2023
Q3 | $414K | Sell |
|
|||||
|
2023
Q2 | $469K | Sell |
|
|||||
|
2023
Q1 | $531K | Sell |
|
|||||
|
2022
Q4 | $680K | Buy |
|
|||||
|
2022
Q3 | $549K | Sell |
|
|||||
|
2022
Q2 | $675K | Sell |
|
|||||
|
2022
Q1 | $690K | Buy |
|
|||||
|
2021
Q4 | $516K | Sell |
|
|||||
|
2021
Q3 | $378K | Sell |
|
|||||
|
2021
Q2 | $389K | Sell |
|
|||||
|
2021
Q1 | $900K | Buy |
|
|||||
|
2020
Q4 | $885K | Buy |
|
|||||
|
2020
Q3 | $509K | Buy |
|
|||||
|
2020
Q2 | $394K | Sell |
|
|||||
|
2020
Q1 | $406K | Sell |
|
|||||
|
2019
Q4 | $497K | Buy |
|
|||||
|
2019
Q3 | $441K | Sell |
|
|||||
|
2019
Q2 | $536K | Buy |
|
|||||
|
2019
Q1 | $515K | Hold |
|
|||||
|
2018
Q4 | $530K | Sell |
|
|||||
|
2018
Q3 | $658K | Buy |
|
|||||
|
2018
Q2 | $494K | Sell |
|
|||||
|
2018
Q1 | $505K | Buy |
|
|||||
|
2017
Q4 | $504K | Sell |
|
|||||
|
2017
Q3 | $501K | Sell |
|
|||||
|
2017
Q2 | $485K | Sell |
|
|||||
|
2017
Q1 | $656K | Sell |
|
|||||
|
2016
Q4 | $626K | Buy |
|
|||||
|
2016
Q3 | $639K | Hold |
|
|||||
|
2016
Q2 | $664K | Sell |
|
|||||
|
2016
Q1 | $564K | Hold |
|
|||||
|
2015
Q4 | $614K | Buy |
|
|||||
|
2015
Q3 | $565K | Sell |
|
|||||
|
2015
Q2 | $631K | Buy |
|
|||||
|
2015
Q1 | $650K | Buy |
|
|||||
|
2014
Q4 | $580K | Buy |
|